Kiniksa Pharmaceuticals International (KNSA) Intangibles (2021 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted Intangibles of $14.75 million for Q2 2026, down 6.3% from $15.75 million a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Intangibles (2021 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International's Intangibles came in at $15.25 million, down 6.2% from FY2024.
- Annual Intangibles has declined for four consecutive years, with a four-year compound annual growth rate of -5.7% (FY2021 to FY2025).
- In prior years, Kiniksa Pharmaceuticals International's Intangibles was $16.25 million in FY2024 (-5.8%), $17.25 million in FY2023 (-5.5%), $18.25 million in FY2022 (-5.2%) and $19.25 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Intangibles in data going back to Q1 2021.
- On a year-over-year basis, Intangibles has declined in each of the last 18 quarters, with an average decline of 6.0% over the last eight quarters.
- The year-over-year decline in Intangibles has ranged between 5.0% (Q1 2022) and 6.3% (Q2 2026) over the last five years.
- According to Business Quant data, Intangibles for the three prior quarters was $15 million (Q1 2026), $15.25 million (Q4 2025) and $15.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn | 14.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.75 Mn |
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | 15.25 Mn |
| Sep 30, 2025 | 15.50 Mn |
| Jun 30, 2025 | 15.75 Mn |
| Mar 31, 2025 | 16.00 Mn |
| Dec 31, 2024 | 16.25 Mn |
| Sep 30, 2024 | 16.50 Mn |
| Jun 30, 2024 | 16.75 Mn |
| Mar 31, 2024 | 17.00 Mn |
| Dec 31, 2023 | 17.25 Mn |
| Sep 30, 2023 | 17.50 Mn |
| Jun 30, 2023 | 17.75 Mn |
| Mar 31, 2023 | 18.00 Mn |
| Dec 31, 2022 | 18.25 Mn |
| Sep 30, 2022 | 18.50 Mn |
| Jun 30, 2022 | 18.75 Mn |
| Mar 31, 2022 | 19.00 Mn |
| Dec 31, 2021 | 19.25 Mn |
| Sep 30, 2021 | 19.50 Mn |
API Access
Kiniksa Pharmaceuticals International Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();